(S)-7-Dipropylamino-5,6,7,8-tetrahydro-indolizine-3-carbaldehyde

ID: ALA316983

PubChem CID: 10014924

Max Phase: Preclinical

Molecular Formula: C15H24N2O

Molecular Weight: 248.37

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1

Standard InChI:  InChI=1S/C15H24N2O/c1-3-8-16(9-4-2)13-7-10-17-14(11-13)5-6-15(17)12-18/h5-6,12-13H,3-4,7-11H2,1-2H3/t13-/m0/s1

Standard InChI Key:  RIOOLQVLOZQLQJ-ZDUSSCGKSA-N

Molfile:  

     RDKit          2D

 18 19  0  0  1  0  0  0  0  0999 V2000
    9.8792   -2.5500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.5917   -2.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0542   -3.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5917   -1.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2167   -2.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8792   -3.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1667   -2.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8792   -0.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1667   -1.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8792   -0.0750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5042   -3.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7667   -4.7542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5917    0.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1667    0.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1667    1.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5917    1.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4542    1.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3125    1.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  2  2  0
  6  3  2  0
  7  1  1  0
  8  9  1  0
  9  7  1  0
  8 10  1  6
 11  3  1  0
 12 11  2  0
 13 10  1  0
 14 10  1  0
 15 14  1  0
 16 13  1  0
 17 15  1  0
 18 16  1  0
  5  6  1  0
  4  8  1  0
M  END

Associated Targets(Human)

DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

DRD1 Dopamine D1 receptor (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Dopamine D2 receptor (774 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd2 Dopamine D2 receptor (7893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 248.37Molecular Weight (Monoisotopic): 248.1889AlogP: 2.74#Rotatable Bonds: 6
Polar Surface Area: 25.24Molecular Species: BASEHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.75CX LogP: 2.54CX LogD: 0.22
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.72Np Likeness Score: -0.71

References

1. Lehmann T, Hübner H, Gmeiner P..  (2001)  Dopaminergic 7-aminotetrahydroindolizines: ex-chiral pool synthesis and preferential D3 receptor binding.,  11  (21): [PMID:11597417] [10.1016/s0960-894x(01)00564-9]
2. Boeckler F, Ohnmacht U, Lehmann T, Utz W, Hübner H, Gmeiner P..  (2005)  CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists.,  48  (7): [PMID:15801839] [10.1021/jm049269+]
3. Elsner J, Boeckler F, Heinemann FW, Hübner H, Gmeiner P..  (2005)  Pharmacophore-guided drug discovery investigations leading to bioactive 5-aminotetrahydropyrazolopyridines. Implications for the binding mode of heterocyclic dopamine D3 receptor agonists.,  48  (18): [PMID:16134944] [10.1021/jm0503805]

Source